Background and purpose: -Gram negative sepsis is a leading cause of mortality in case of complicated intra-abdominal infections due to the deficit clinically viable options for therapy. The purpose of the present study was to investigate potential of intracorporeal chitosan coated curcumin nanocrystals (Chi-CUR-10 NC-4b) as a parenteral therapeutic approach against endotoxemia induced sepsis. Experimental Approaches: -Curcumin (CUR) nanocrystals were fabricated with high pressure homogenization and coated with chitosan. These nanocrystals were evaluated for 15 physiochemical and pharmacokinetic parameters. Comparative evaluations were also made between Chi-CUR-NC-4b and CUR in LPS stimulated HepG2 and J774 cells, as well as in the murine model of LPS induced sepsis for PK, Pharmacodynamic parameters and survival studies. 20 Key Results:-Chi-CUR-NC4b (with D 95% and zeta potential , 443±15.76 nm and+28.82±1.52 mV respectively) was found to neutralize LPS and enhanced plasma drug concentration (16 times as compared to CUR solution) along with improved levels in organs of interest i.e. lungs and liver. In-vitro and in-vivo 25 pharmacodynamic studies demonstrated that the protective effects were mediated by up-regulation of Nrf2 (enhanced antioxidant activity i.e. via elevated levels of SOD and GST) as well as via down regulation of NFκB leading to reduced cytokine secretion in the murine model of sepsis. Furthermore, reduction in tissue 30 injury (attributed to reduced neutrophil migration indicated by myeloperoxidase levels) also contributed to enhanced survival in murine model of LPS induced endotoxemia. Conclusions and implications: -These results together evoke that developed curcumin bearing nano-formulation could serve as 35 a valuable option for therapeutic intervention of sepsis and associated hyper inflammatory disorders. Graphical abstract: 40